Pine Bridge Investments, L.P. Charles River Laboratories International, Inc. Transaction History

Pine Bridge Investments, L.P.

$12.2 Billion
Q1 2025

A detailed history of Pine Bridge Investments, L.P. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 17,029 shares of CRL stock, worth $3.05 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

17,029

Previous 112,625 84.88%

Holding current value

$3.05 Million

Previous $20.8 Million 87.67%

% of portfolio

0.02%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$150.52 - $190.14 $14.4 Million - $18.2 Million	-95,596 Reduced 84.88%	17,029 $2.56 Million
Q4 2024 Feb 14, 2025	SELL	$178.58 - $220.69 $4.21 Million - $5.2 Million	-23,584 Reduced 17.31%	112,625 $20.8 Million
Q3 2024 Nov 14, 2024	BUY	$187.96 - $245.29 $1.47 Million - $1.92 Million	7,823 Added 6.09%	136,209 $26.8 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $928,135 - $1.21 Million	4,497 Added 3.63%	128,386 $26.5 Million
Q1 2024 May 14, 2024	BUY	$203.52 - $273.43 $4.78 Million - $6.43 Million	23,508 Added 23.42%	123,889 $33.6 Million
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $3.1 Million - $4.5 Million	18,849 Added 23.12%	100,381 $23.7 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $1.42 Million - $1.58 Million	7,278 Added 9.8%	81,532 $16 Million
Q2 2023 Aug 11, 2023	SELL	$183.71 - $210.25 $448,619 - $513,430	-2,442 Reduced 3.18%	74,254 $15.6 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $1.28 Million - $1.74 Million	6,676 Added 9.53%	76,696 $15.5 Million
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $2.75 Million - $3.49 Million	13,958 Added 24.9%	70,020 $15.3 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $599,497 - $823,274	3,286 Added 6.23%	56,062 $11 Million
Q2 2022 Aug 05, 2022	BUY	$204.13 - $302.4 $345,796 - $512,265	1,694 Added 3.32%	52,776 $11.3 Million
Q1 2022 May 12, 2022	BUY	$255.51 - $362.11 $6.2 Million - $8.79 Million	24,267 Added 90.5%	51,082 $14.5 Million
Q4 2021 Feb 10, 2022	SELL	$351.38 - $448.68 $1.2 Million - $1.54 Million	-3,428 Reduced 11.33%	26,815 $10.1 Million
Q3 2021 Nov 09, 2021	SELL	$372.64 - $458.3 $7.89 Million - $9.7 Million	-21,169 Reduced 41.18%	30,243 $12.5 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $4.32 Million - $5.46 Million	14,700 Added 40.04%	51,412 $19 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $1.11 Million - $1.26 Million	-4,986 Reduced 11.96%	36,712 $9.17 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $1.21 Million - $1.57 Million	6,914 Added 19.88%	41,698 $9.44 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $4.13 Million - $6.6 Million	34,784 New	34,784 $6.07 Million

Others Institutions Holding CRL

# of Institutions

625

Shares Held

55M

Call Options Held

722K

Put Options Held

847K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.

Account

Pine Bridge Investments, L.P. Charles River Laboratories International, Inc. Transaction History